Nematospiroides dubius: mechanisms of host immunity. II. Skin testing and immunosuppression of orally or subcutaneously sensitized mice.
D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000302:isolation & purification; D000961:Antilymphocyte Serum / Q000008:administration & dosage; D003533:Cyproheptadine / Q000008:administration & dosage; D006084:Graft Rejection; D007165:Immunosuppression Therapy; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007421:Intestine, Small / Q000473:pathology; D007814:Larva / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D051379:Mice; D011817:Rabbits / Q000276:immunology; D012882:Skin Tests; D016038:Skin Transplantation; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous; D014251:Trichostrongyloidea / Q000276:immunology; D014252:Trichostrongyloidiasis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology* / Q000473:pathology
D000941:Antigens; D000961:Antilymphocyte Serum; D007978:Levamisole; D003533:Cyproheptadine